Astellas Stays Competitive in Hot Gut Cancer Target, Paying $130M to License Evopoint Drug
Astellas Pharma already has the primary FDA approval for a remedy that goes after Claudin 18.2, a protein whose overexpression ...
Astellas Pharma already has the primary FDA approval for a remedy that goes after Claudin 18.2, a protein whose overexpression ...
A Houston urologist had his medical license revoked after testing constructive for cocaine, following earlier allegations of him performing surgical ...
Indian medical imaging AI firm Qure.ai has developed a brand new AI-powered co-pilot for optimising sources in resource-constrained main care...
Copyright © 2024 Agarwood Times.
Agarwood Times is not responsible for the content of external sites.
Copyright © 2024 Agarwood Times.
Agarwood Times is not responsible for the content of external sites.